Iovance Biotherapeutics, Inc.

8-K Other events Jul 2, 2026 8-K Shareholder vote results; Other events Jun 10, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change Mar 20, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release); Other events Feb 24, 2026 8-K Other events Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Other events Aug 29, 2025 8-K Entered a material agreement Aug 22, 2025 8-K Other events Aug 19, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release); Director or officer change Aug 7, 2025 8-K Director or officer change; Other events Jul 15, 2025 8-K Director or officer change Jul 3, 2025 8-K Director or officer change Jun 13, 2025 8-K Shareholder vote results Jun 10, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Other events Feb 10, 2025 8-K Entered a material agreement; Terminated a material agreement Nov 21, 2024 8-K Other events Nov 8, 2024 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Aug 9, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Other events Jun 28, 2024 8-K Shareholder vote results Jun 11, 2024 8-K Other events Jun 3, 2024 8-K Other events May 24, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Other events Apr 3, 2024 8-K Director or officer change; Amended charter or bylaws Mar 29, 2024 8-K Other events Mar 4, 2024